Diagnos Laboratorium Utama Tbk. vs Multikarya Asia Pasifik Raya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Multikarya Asia Pasifik Raya Tbk. trades at Rp1,165 (market cap 3.79T, 336.3K 24h volume). The key difference: Multikarya Asia Pasifik Raya Tbk. is far larger — about 12.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 336.3K). Which is the better fit depends on your goals.
| DGNS | MKAP | |
|---|---|---|
Market Cap | 310.75B | 3.79T |
Volume | 963.6K | 336.3K |
Lot | 9.64K | 3.36K |
Turnover | 217.67M | 389.33M |
Average Price | 225.89 | 1,157.68 |
Value | 217.67M | 389.33M |
Indicative Equilibrium Price | 226 | 1,165 |
Indicative Equilibrium Volume | 1K | 2.5K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.
Read more on MKAP →